OraSure Technologies Inc. (NASDAQ: OSUR) is a globally-recognized leader in the development, manufacture, and distribution of point-of-care diagnostic tests, molecular collection systems, and other technologies designed to detect and diagnose critical medical conditions. With its operational headquarters in Bethlehem, Pennsylvania, OraSure Technologies, or simply OraSure, has been pioneering progress in the global health industry for over 30 years.
Founded in 1987, OraSure Technologies originally started as SolarCare Technologies Corporation focused on the pharmaceutical industry. The company later rebranded and expanded its scope to cover medical device production, becoming a trailblazer in oral fluid technology.
Currently, OraSure's expansive portfolio of products targets various health-related issues, including HIV, Ebola, and Hepatitis C. The company gained global attention with its OraQuick ADVANCED® Rapid HIV-1/2 Antibody Test, the first FDA-approved oral fluid rapid test for HIV-1/2. It also manufactures the acclaimed OraQuick®Ebola Rapid Antigen Test and the OraQuick®HCV test.
One of OraSure's recent achievements is developing a molecular collection systems marketed under the Oragene® brand. These DNA and RNA collection systems were designed to maximize the precision and reliability of genetic testing.
More recently, in light of the global COVID-19 pandemic, OraSure has also directed its expertise towards contributing to coronavirus detection and control. It has received grant funding from the Biomedical Advanced Research and Development Authority (BARDA) to work toward the development of an in-home self-test for the novel coronavirus.
OraSure's dedication to healthcare and innovation has earned it a reputation of reliability and trust among clinicians, patients, and consumers globally. The company is dedicated to making testing simple, accessible, and reliable, and its products are sold in over 60 countries worldwide.
The commitment to enhancing global health is not only reflected in OraSure's product portfolio but also in its business operations. The company is committed to protecting and fostering human rights, minimizing its impact on the environment, and supporting the communities where it does business. OraSure Technologies’ mission and impact stretch far beyond its ongoing innovations in diagnostic testing, mimicking its dedication to contributing positively towards global healthcare.